HeartBeam has submitted a 510 (k) application to the US Food and Drug Administration (FDA) for its 12-lead electrocardiogram ...
Advancements and Projections in the Global Cardiac Rhythm Management Devices Market: Insights, Trends, Opportunities, and ...
The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five ...
HeartBeam (NASDAQ: BEAT) , a medical technology company advancing cardiac care, has submitted a 510 (k) application to the U.S. Food and Drug Administration (“FDA”) for its 12-lead electrocardiogram ( ...
SANTA CLARA, Calif. - HeartBeam, Inc. (NASDAQ: BEAT), a $56.5 million market cap pioneer in medical technology currently trading at $2.12 per share, has announced the submission of a 510(k) ...
Stopping blood thinners before or during surgery for a CIED may result in little to no difference in undesirable outcomes such as blood clots or bleeding events when compared to taking them ...
NANS attendees are invited to visit booth #213 to learn more about how Integer can serve as a strategic partner of choice in amplifying customers’ innovation and increasing speed to market. More ...
When someone's heart stops pumping, early CPR can save their life. New survey research from the American Heart Association ...
"The integration of Lucia into UpBeat.org aligns perfectly with our mission to provide innovative resources for patients and ...
The cardiac pacemaker market has witnessed significant growth over recent years, driven by the increasing prevalence of heart diseases, advancements in pacemaker technology, and growing awareness ...
Much has changed since the 2013 document came out, with new information on pacing devices, techniques, and more.